about
Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy.The CD133+ cell as advanced medicinal product for myocardial and limb ischemia.Temporal Trends and Temperature-Related Incidence of Electrical Storm: The TEMPEST Study (Temperature-Related Incidence of Electrical Storm).Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.Cell therapy for heart disease after 15 years: Unmet expectations.Initial international multicenter human experience with a novel epicardial access needle embedded with a real-time pressure/frequency monitoring to facilitate epicardial access: Feasibility and safety.Electroanatomical mapping systems and intracardiac echo integration for guided endomyocardial biopsy.An easy-to-use, operator-independent, clinical model to predict the left vs. right ventricular outflow tract origin of ventricular arrhythmias.Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation.Use of levosimendan for treatment of cardiogenic shock associated with electrical storm.Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.Long-term follow-up after radiofrequency catheter ablation of atrial fibrillation: role of the acute procedure outcome and of the clinical presentation.Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy.Cell Therapy for Refractory Angina: A Reappraisal.Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients.Novel Application of 3-Dimensional Real-Time Cardiac Imaging to Guide Stem Cell-Based Therapy.High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results.Image integration-guided catheter ablation of atrial fibrillation: a prospective randomized study.Uncommon ventricular tachycardia originating from an interventricular septal aneurism: Mapping and ablation guided by real-time image integration.X-Ray Exposure in Cardiac Electrophysiology: A Retrospective Analysis in 8150 Patients Over 7 Years of Activity in a Modern, Large-Volume Laboratory.Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)Feasibility and safety of catheter ablation of electrical storm in ischemic dilated cardiomyopathyReplyDrug-Refractory Ventricular Tachycardias After MyocarditisEndo-Epicardial Homogenization of the Scar Versus Limited Substrate Ablation for the Treatment of Electrical Storms in Patients With Ischemic CardiomyopathyRadiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in NonrespondersRadiofrequency Catheter Ablation of Life-Threatening Ventricular Arrhythmias Caused by Left Ventricular Metastatic InfiltrationAssessment of cardiac resynchronization therapy responseValue of analysis of ST segment changes during tachycardia in determining type of narrow QRS complex tachycardiaPersistence of single echo beat inducibility after selective ablation of the slow pathway in patients with atrioventricular nodal reentrant tachycardia: relationship to the functional properties of the atrioventricular node and clinical implicationsModulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutterIncidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatmentAtypical atrial flutter: clinical features, electrophysiological characteristics and response to radiofrequency catheter ablationCharacterization of left ventricular activation in patients with heart failure and left bundle-branch blockModulation of the atrioventricular node conduction to achieve rate control in patients with atrial fibrillation: long-term resultsRadiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation
P50
Q31386833-917C2C31-AFC6-47B0-A28F-9AB79DFAF9EBQ33161166-0A6C2F8E-44DB-4B70-AD6F-28FD6642F8E3Q33881246-8C0314E3-988F-468B-B995-50DF7618CED3Q38228388-73B230EB-5194-47B1-B1D9-E6605F529730Q38379310-7DFE21B3-1C72-48CB-90CA-D2C92EFCD456Q38940528-AA77403A-B0E5-4FF2-93B7-337FEEC60FCFQ39149897-A974413A-B735-44F3-BBE9-DA4564D433DDQ39166206-F000BED7-BD33-4C96-B46C-B456E52E7B5CQ39415461-798C002E-CC16-41C3-8473-0274B05EFCA9Q41448800-B0A9A776-2CE4-4619-9FC3-1FFF7345A1E8Q44654348-D7A59658-7B01-4CD9-A64D-471AD9C631A0Q46006704-CB04800F-A97A-43B3-9713-0864C65ECDF7Q46038253-C7B2BB9D-33D6-43A0-ACB0-4F19E44BF687Q46373980-B4DF5A84-3A74-4F79-83FE-EECC9552EF80Q46562734-7C7EDDFD-0E81-45EF-B23E-793E894B4BFDQ48155875-A08D65CE-3DA0-4E5A-8F42-8965E04461A9Q48384013-30B663BD-00FA-44FA-BFE9-B990742CF7F2Q50962762-2839ECB4-13BA-4C74-851F-00CB88E6DFA5Q51782114-97F5CEAD-128C-4FBA-9101-A33D4A62A564Q52064578-DB9942D8-EFB8-4204-8B77-2EB3867DCB9CQ52562544-3ABFFFFD-C9BB-4D50-9CDA-82C10C04EC5CQ53365860-28A19490-BF06-42E7-925E-2F96A372502AQ53571950-BC5A3DEF-C1E1-4145-8347-1BAA46D0589EQ55413659-DDA35588-35CD-4F55-BE2F-56C1FADC0C26Q58741622-B3F0E44F-DD1C-42CC-A49F-42EC83A77426Q59248741-DED31D01-694B-4008-BDDC-5A7E602F7DF1Q59248743-7CBB8C12-05DE-4AB0-82A6-D2EAC1C1EA0FQ59248761-F8EF4A5E-FF5F-4668-85A5-7F4B204B1DD0Q59248762-7891C7C5-3080-4915-8BFF-1F133DDC617BQ59248767-01D98363-15AA-4664-A5F3-7925EDBF53FCQ59248779-A60A2681-EFE6-4BBC-9560-3F65C5140324Q60808238-BC7D37C6-4A1C-4C82-98C6-0FD658568402Q71071094-18073782-BDA4-4876-ACD6-592DD53ED258Q71653929-214B0327-8F5D-4B9A-9EC2-5B6D25977A80Q72352921-220B3A4C-B94D-46D5-AC49-F7724173FBDDQ73545519-A7EA1465-B382-4808-AB18-B8DD81297915Q74502881-1361EA06-78F1-4E70-B8C0-7C1E1110E0D6Q76392700-FBC29D4A-2A9C-46B9-9570-C41EC5B08E91Q77229640-85DE4283-1A27-46B9-BCF3-7FEC28D4814DQ77769372-047ECED1-065E-4F0F-9FA1-568A887E259F
P50
description
researcher ORCID ID = 0000-0001-5954-537X
@en
name
Corrado Carbucicchio
@ast
Corrado Carbucicchio
@en
Corrado Carbucicchio
@es
Corrado Carbucicchio
@nl
type
label
Corrado Carbucicchio
@ast
Corrado Carbucicchio
@en
Corrado Carbucicchio
@es
Corrado Carbucicchio
@nl
prefLabel
Corrado Carbucicchio
@ast
Corrado Carbucicchio
@en
Corrado Carbucicchio
@es
Corrado Carbucicchio
@nl
P1153
6602836793
P31
P496
0000-0001-5954-537X